UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001849
Receipt No. R000002118
Scientific Title phase II study of Erlotinib for non-small cell lung cancer patients with EGFR mutation
Date of disclosure of the study information 2009/04/04
Last modified on 2012/04/23 00:46:16

No. Disposal Last modified on Item of update
1 Insert 2009/04/04 15:49:35
2 Update 2009/10/28 21:44:46 Recruitment status
3 Update 2010/10/12 09:05:01 Last follow-up date
4 Update 2011/05/09 11:08:06 Name of person sending information
Organization
Division name
Address
5 Update 2011/05/09 11:08:48 Last follow-up date
6 Update 2011/11/05 21:22:27 Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2011/11/05 21:24:03 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2012/04/23 00:43:55 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2012/04/23 00:44:22 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
10 Update 2012/04/23 00:46:16 Recruitment status


Contact us.